Literature DB >> 12916817

Central obesity and breast cancer risk: a systematic review.

M Harvie1, L Hooper, A H Howell.   

Abstract

The specific effect of central rather than general obesity on breast cancer risk is not clear. This review examines the relationship between waist and waist-hip ratio (WHR) and risk of breast cancer in pre- and post-menopausal women using all available cohort and case-control data. The databases of the Cochrane Library, Medline, Cancer Lit and Embase were searched until October 2002. Relevant cohort and case-control studies with separate analyses in pre- and/or post-menopausal women were included. Random effects meta-analyses were carried out, subgrouped by pre- or post-menopausal status and cohort or case-control design. Sensitivity analyses were also performed. Five cohort studies with 72,1705 person years of observation (453 pre-menopausal and 2684 post-menopausal cases), and three case-control studies comprising 276 pre-menopausal cases with 758 pre-menopausal controls and 390 post-menopausal cases with 1071 post-menopausal controls were included. Pooled results from cohort studies using the most adjusted data [but without adjustment for weight or body mass index (BMI)] suggest a 39% lower risk of breast cancer in post-menopausal women with the smallest waist (compared with the largest) and a 24% lower risk in women with the smallest WHR. In pre-menopausal women, however, pooled results suggest that measurement of waist or WHR have little effect on risk of breast cancer. Adjustment for BMI abolished the relationship between waist or WHR and risk of post-menopausal breast cancer, but introduced such a relationship amongst pre-menopausal women. The relationship between a smaller measurement of waist or WHR and lower risk of post-menopausal breast cancer appears to result from the associated correlation with BMI. Amongst pre-menopausal women, central (not general) obesity may be specifically associated with an increased risk of breast cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12916817     DOI: 10.1046/j.1467-789x.2003.00108.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  125 in total

1.  Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Authors:  Debora Macis; Sara Gandini; Aliana Guerrieri-Gonzaga; Harriet Johansson; Paolo Magni; Massimiliano Ruscica; Matteo Lazzeroni; Davide Serrano; Massimiliano Cazzaniga; Serena Mora; Irene Feroce; Maria Pizzamiglio; Maria Teresa Sandri; Marcella Gulisano; Bernardo Bonanni; Andrea Decensi
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  A case-control study of body mass index and breast cancer risk in white and African-American women.

Authors:  Paula Berstad; Ralph J Coates; Leslie Bernstein; Suzanne G Folger; Kathleen E Malone; Polly A Marchbanks; Linda K Weiss; Jonathan M Liff; Jill A McDonald; Brian L Strom; Michael S Simon; Dennis Deapen; Michael F Press; Ronald T Burkman; Robert Spirtas; Giske Ursin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 3.  Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective.

Authors:  Elisa V Bandera; Gertraud Maskarinec; Isabelle Romieu; Esther M John
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

4.  The association between metabolic health, obesity phenotype and the risk of breast cancer.

Authors:  Yong-Moon Mark Park; Alexandra J White; Hazel B Nichols; Katie M O'Brien; Clarice R Weinberg; Dale P Sandler
Journal:  Int J Cancer       Date:  2017-03-28       Impact factor: 7.396

5.  Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Stephanie R Land; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-07

6.  Obesity-related cancer: an emerging need for more education.

Authors:  Paulette Mehta; Ronda Henry-Tillman
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

7.  Epidemiology of basal-like breast cancer.

Authors:  Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2007-06-20       Impact factor: 4.872

8.  Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

Authors:  Xiang Shu; Lang Wu; Nikhil K Khankari; Xiao-Ou Shu; Thomas J Wang; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Joe Dennis; Roger L Milne; Marjanka K Schmidt; Paul D P Pharoah; Irene L Andrulis; David J Hunter; Jacques Simard; Douglas F Easton; Wei Zheng
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

9.  CREB-regulated transcription co-activator family stimulates promoter II-driven aromatase expression in preadipocytes.

Authors:  Nirukshi U Samarajeewa; Maria M Docanto; Evan R Simpson; Kristy A Brown
Journal:  Horm Cancer       Date:  2013-04-13       Impact factor: 3.869

10.  Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells.

Authors:  Cinzia Giordano; Donatella Vizza; Salvatore Panza; Ines Barone; Daniela Bonofiglio; Marilena Lanzino; Diego Sisci; Francesca De Amicis; Suzanne A W Fuqua; Stefania Catalano; Sebastiano Andò
Journal:  Mol Oncol       Date:  2012-11-23       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.